BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 7665619)

  • 1. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation.
    Lamphear BJ; Kirchweger R; Skern T; Rhoads RE
    J Biol Chem; 1995 Sep; 270(37):21975-83. PubMed ID: 7665619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single amino acid change in protein synthesis initiation factor 4G renders cap-dependent translation resistant to picornaviral 2A proteases.
    Lamphear BJ; Rhoads RE
    Biochemistry; 1996 Dec; 35(49):15726-33. PubMed ID: 8961935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteolytic cleavage of eukaryotic initiation factor (eIF) 4G is prevented by eIF4E binding protein (PHAS-I; 4E-BP1) in the reticulocyte lysate.
    Ohlmann T; Pain VM; Wood W; Rau M; Morley SJ
    EMBO J; 1997 Feb; 16(4):844-55. PubMed ID: 9049313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cap-independent translation initiation in Xenopus oocytes.
    Keiper BD; Rhoads RE
    Nucleic Acids Res; 1997 Jan; 25(2):395-402. PubMed ID: 9016570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G.
    Ali IK; McKendrick L; Morley SJ; Jackson RJ
    J Virol; 2001 Sep; 75(17):7854-63. PubMed ID: 11483729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E.
    Ohlmann T; Rau M; Pain VM; Morley SJ
    EMBO J; 1996 Mar; 15(6):1371-82. PubMed ID: 8635470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus.
    Lamphear BJ; Yan R; Yang F; Waters D; Liebig HD; Klump H; Kuechler E; Skern T; Rhoads RE
    J Biol Chem; 1993 Sep; 268(26):19200-3. PubMed ID: 8396129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap-dependent translation, and the C-terminal one-third functions as a modulatory region.
    Morino S; Imataka H; Svitkin YV; Pestova TV; Sonenberg N
    Mol Cell Biol; 2000 Jan; 20(2):468-77. PubMed ID: 10611225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new translational regulator with homology to eukaryotic translation initiation factor 4G.
    Imataka H; Olsen HS; Sonenberg N
    EMBO J; 1997 Feb; 16(4):817-25. PubMed ID: 9049310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extremely efficient cleavage of eIF4G by picornaviral proteinases L and 2A in vitro.
    Glaser W; Skern T
    FEBS Lett; 2000 Sep; 480(2-3):151-5. PubMed ID: 11034318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase.
    Haghighat A; Svitkin Y; Novoa I; Kuechler E; Skern T; Sonenberg N
    J Virol; 1996 Dec; 70(12):8444-50. PubMed ID: 8970966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human rhinovirus 2A proteinase cleavage sites in eukaryotic initiation factors (eIF) 4GI and eIF4GII are different.
    Gradi A; Svitkin YV; Sommergruber W; Imataka H; Morino S; Skern T; Sonenberg N
    J Virol; 2003 Apr; 77(8):5026-9. PubMed ID: 12663812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
    Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
    J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic initiation factors 4A (eIF4A) and 4G (eIF4G) mutually interact in a 1:1 ratio in vivo.
    Li W; Belsham GJ; Proud CG
    J Biol Chem; 2001 Aug; 276(31):29111-5. PubMed ID: 11408474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eukaryotic initiation factor 4G-poly(A) binding protein interaction is required for poly(A) tail-mediated stimulation of picornavirus internal ribosome entry segment-driven translation but not for X-mediated stimulation of hepatitis C virus translation.
    Michel YM; Borman AM; Paulous S; Kean KM
    Mol Cell Biol; 2001 Jul; 21(13):4097-109. PubMed ID: 11390639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human eukaryotic translation initiation factor 4G (eIF4G) possesses two separate and independent binding sites for eIF4A.
    Imataka H; Sonenberg N
    Mol Cell Biol; 1997 Dec; 17(12):6940-7. PubMed ID: 9372926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of polypeptide chain initiation factor eIF4GI during apoptosis in lymphoma cells: characterisation of an internal fragment generated by caspase-3-mediated cleavage.
    Bushell M; Poncet D; Marissen WE; Flotow H; Lloyd RE; Clemens MJ; Morley SJ
    Cell Death Differ; 2000 Jul; 7(7):628-36. PubMed ID: 10889507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutually cooperative binding of eukaryotic translation initiation factor (eIF) 3 and eIF4A to human eIF4G-1.
    Korneeva NL; Lamphear BJ; Hennigan FL; Rhoads RE
    J Biol Chem; 2000 Dec; 275(52):41369-76. PubMed ID: 11022043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5'-Cap by domains of eIF4G.
    von Der Haar T; Ball PD; McCarthy JE
    J Biol Chem; 2000 Sep; 275(39):30551-5. PubMed ID: 10887196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cap-dependent eukaryotic initiation factor-mRNA interactions probed by cross-linking.
    Lindqvist L; Imataka H; Pelletier J
    RNA; 2008 May; 14(5):960-9. PubMed ID: 18367715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.